All-Cause and Cause-Specific Mortality in Middle-Aged Individuals with Positive HBsAg: Findings from a Prospective Cohort Study

• Published in: Archives of Iranian medicine Vol. 25; no. 3; pp. 139 - 147
• Main Authors: Motamed-Gorji, Nazgol, Eghtesad, Sareh, Sharafkhah, Maryam, Masoudi, Sahar, Darvishian, Maryam, Eslami, Layli, Gharavi, Abdolsamad, Khoshnia, Masoud, Roshandel, Gholamreza, Shayanrad, Amaneh, Hariri, Sanam, Merat, Shahin, Poustchi, Hossein, Malekzadeh, Reza
• Format: Journal Article
• Language: English
• Published: Iran Academy of Medical Sciences of I.R. Iran 01-03-2022
• Subjects: Adult; Cancer; Cardiovascular disease; Cause of Death; Cohort analysis; Cohort Studies; Epidemiology; Female; Hepatitis; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Iran - epidemiology; Liver; Liver diseases; Liver transplants; Male; Middle age; Middle Aged; Mortality; Neoplasms - complications; Prospective Studies; Risk Factors; Iran; Hepatitis B virus; Iran; Cohort study; Mortality
• ISSN: 1029-2977; 1735-3947
• DOI: 10.34172/aim.2022.24

While hepatitis B virus (HBV) is the most prevalent cause of adult liver transplants in Iran, the mortality rates and leading causes of death in HBV patients are not well-understood. This study aimed to investigate all-cause and cause-specific mortality among HBsAg positive individuals in a large Iranian cohort.
The Golestan Cohort Study includes 50045 individuals aged 40-75 residing in Iran's Golestan province, enrolled during 2004-2008. HBsAg test was performed at baseline. For the present study, individuals with hepatitis C coinfection were excluded. All-cause mortality was considered as the primary outcome. The association between HBsAg and different mortality causes was evaluated using Cox proportional hazard models.
value<0.05 was considered significant.
The current study included 49667 participants. After 11.33 (median) follow-up years, there were 7,686 total deaths, with 635 deaths in the HBsAg positive group. In the multivariate Cox proportional hazard model, HBsAg positive individuals had higher all-cause (adjusted hazard ratio [aHR]=1.15, 95% CI: 1.06-1.24) and liver-related mortality risk (aHR=7.13; 5.19-9.79). Mortality from colorectal and pancreatic cancers was higher among male HBsAg positive participants (aHRs=2.41 and 2.22, respectively). Nevertheless, cardiovascular diseases (CVDs) and extrahepatic malignancies were the leading causes of death among both HBsAg positive and negative individuals, and liver-related deaths contributed to an overall 10% of deaths in HBsAg positive patients.
HBV is associated with significant mortality risk from different causes in Iranian adults. However, solely focusing on liver outcomes in Iranian HBV patients might result in overlooking non-liver events, especially CVD and extrahepatic cancers.